Mammary cancer susceptibility: human genes and rodent models

被引:18
作者
Szpirer, Claude [1 ]
Szpirer, Josiane [1 ]
机构
[1] Univ Libre Bruxelles, Inst Biol & Med Mol, B-6041 Gosselies, Charleroi, Belgium
关键词
QUANTITATIVE TRAIT LOCUS; ESTROGEN-INDUCED TUMORIGENESIS; GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-ALPHA; BREAST-CANCER; SUPPRESSOR GENE; TRANSGENIC MICE; FANCONI-ANEMIA; OVARIAN-CANCER; CARCINOMA SUSCEPTIBILITY;
D O I
10.1007/s00335-007-9073-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Breast cancer is a complex disease, showing a strong genetic component. Several human susceptibility genes have been identified, especially in the last few months. Most of these genes are low-penetrance genes and it is clear that numerous other susceptibility genes remain to be identified. The function of several susceptibility genes indicates that one critical biological pathway is the DNA damage response. However, other pathways certainly play a significant role in breast cancer susceptibility. Rodent models of breast cancer are useful models in two respects. They can help identify new mammary susceptibility genes by taking advantage of the very divergent susceptibilities exhibited by different mouse or rat strains and carrying out relevant genetic analyses. They also provide investigators with experimental systems that can help decipher the mechanism(s) of resistance to mammary cancer. Recent genetic and biological results obtained with mouse and especially with rat strains indicate that (1) numerous quantitative trait loci control mammary cancer susceptibility or resistance, with distinct loci acting in different strains, and (2) distinct resistance mechanisms operate in different rat resistant strains, precocious mammary differentiation being one of these mechanisms.
引用
收藏
页码:817 / 831
页数:15
相关论文
共 161 条
[31]   Cancer susceptibility in the mouse: Genetics, biology and implications for human cancer [J].
Demant, P .
NATURE REVIEWS GENETICS, 2003, 4 (09) :721-734
[32]   Mammary gland oncogenes as indicators of pathways important in mammary gland development [J].
Dickson, C ;
Creer, A ;
Fantl, V .
ONCOGENE, 2000, 19 (08) :1097-1101
[33]   The three Es of cancer immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :329-360
[34]  
DUNNING WF, 1953, CANCER RES, V13, P147
[35]   Genome-wide association study identifies novel breast cancer susceptibility loci [J].
Easton, Douglas F. ;
Pooley, Karen A. ;
Dunning, Alison M. ;
Pharoah, Paul D. P. ;
Thompson, Deborah ;
Ballinger, Dennis G. ;
Struewing, Jeffery P. ;
Morrison, Jonathan ;
Field, Helen ;
Luben, Robert ;
Wareham, Nicholas ;
Ahmed, Shahana ;
Healey, Catherine S. ;
Bowman, Richard ;
Meyer, Kerstin B. ;
Haiman, Christopher A. ;
Kolonel, Laurence K. ;
Henderson, Brian E. ;
Le Marchand, Loic ;
Brennan, Paul ;
Sangrajrang, Suleeporn ;
Gaborieau, Valerie ;
Odefrey, Fabrice ;
Shen, Chen-Yang ;
Wu, Pei-Ei ;
Wang, Hui-Chun ;
Eccles, Diana ;
Evans, D. Gareth ;
Peto, Julian ;
Fletcher, Olivia ;
Johnson, Nichola ;
Seal, Sheila ;
Stratton, Michael R. ;
Rahman, Nazneen ;
Chenevix-Trench, Georgia ;
Bojesen, Stig E. ;
Nordestgaard, Borge G. ;
Axelsson, Christen K. ;
Garcia-Closas, Montserrat ;
Brinton, Louise ;
Chanock, Stephen ;
Lissowska, Jolanta ;
Peplonska, Beata ;
Nevanlinna, Heli ;
Fagerholm, Rainer ;
Eerola, Hannaleena ;
Kang, Daehee ;
Yoo, Keun-Young ;
Noh, Dong-Young ;
Ahn, Sei-Hyun .
NATURE, 2007, 447 (7148) :1087-U7
[36]   A recurrent mutation in PALB2 in Finnish cancer families [J].
Erkko, Hannele ;
Xia, Bing ;
Nikkilae, Jenni ;
Schleutker, Johanna ;
Syrjaekoski, Kirsi ;
Mannermaa, Arto ;
Kallioniemi, Anne ;
Pylkas, Katri ;
Karppinen, Sanna-Maria ;
Rapakko, Katrin ;
Miron, Alexander ;
Sheng, Qing ;
Li, Guilan ;
Mattila, Henna ;
Bell, Daphne W. ;
Haber, Daniel A. ;
Grip, Mervi ;
Reiman, Mervi ;
Jukkola-Vuorinen, Arja ;
Mustonen, Aki ;
Kere, Juha ;
Aaltonen, Lauri A. ;
Kosma, Veli-Matti ;
Kataja, Vesa ;
Soini, Ylermi ;
Drapkin, Ronny I. ;
Livingston, David M. ;
Winqvist, Robert .
NATURE, 2007, 446 (7133) :316-319
[37]   BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS [J].
FUTREAL, PA ;
LIU, QY ;
SHATTUCKEIDENS, D ;
COCHRAN, C ;
HARSHMAN, K ;
TAVTIGIAN, S ;
BENNETT, LM ;
HAUGENSTRANO, A ;
SWENSEN, J ;
MIKI, Y ;
EDDINGTON, K ;
MCCLURE, M ;
FRYE, C ;
WEAVERFELDHAUS, J ;
DING, W ;
GHOLAMI, Z ;
SODERKVIST, P ;
TERRY, L ;
JHANWAR, S ;
BERCHUCK, A ;
IGLEHART, JD ;
MARKS, J ;
BALLINGER, DG ;
BARRETT, JC ;
SKOLNICK, MH ;
KAMB, A ;
WISEMAN, R .
SCIENCE, 1994, 266 (5182) :120-122
[38]   Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk [J].
Gaudet, Mia M. ;
Egan, Kathleen M. ;
Lissowska, Jolanta ;
Newcomb, Polly A. ;
Brinton, Louise A. ;
Titus-Ernstoff, Linda ;
Yeager, Meredith ;
Chanock, Stephen ;
Welch, Robert ;
Peplonska, Beata ;
Trentham-Dietz, Amy ;
Garcia-Closas, Montserrat .
HUMAN GENETICS, 2007, 121 (3-4) :483-490
[39]   Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat:: Mapping of Emca1 and Emca2 to chromosomes 5 and 18 [J].
Gould, KA ;
Tochacek, M ;
Schaffer, BS ;
Reindl, TM ;
Murrin, CR ;
Lachel, CM ;
VanderWoude, EA ;
Pennington, KL ;
Flood, LA ;
Bynote, KK ;
Meza, JL ;
Newton, MA ;
Shull, JD .
GENETICS, 2004, 168 (04) :2113-2125
[40]   RODENT MODELS FOR THE STUDY OF ETIOLOGY, PREVENTION AND TREATMENT OF BREAST-CANCER [J].
GOULD, MN .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (03) :147-152